Work

Abstract CT214: An immune-therapeutic salvage strategy for ‘functional’ high-risk (FHR) multiple myeloma (MM) incorporating iberdomide, isatuximab, and dexamethasone: The IBIS Study AMaRC 20-01

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-ct214

Authors: Sueh-li Lim, John Reynolds, Wojt Janowski, Hang Quach, Philip Campbell, Georgia McCaughan, Nicole Wong Doo, Sophie Hyesuk Lee, Philip Wong, Nina Byard, Khoa Le, An Nguyen, Andrew Spencer

Institutions: The Alfred Hospital, Monash University, Calvary Mater Newcastle Hospital, St Vincent's Hospital Melbourne, Geelong Hospital, St Vincent's Hospital Sydney, Concord Repatriation General Hospital, Western Health, Toowoomba Hospital

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409821648

Cites:

Cited by:

Related to: 10